Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Glu Mobile’s Business Is Improving, but the Stock Is Expensive

GLUU stock has already doubled recently. To keep rising, it will have to build on the recent momentum - simply turning a marginal operating profit isn't enough to support the $6 share price.

Wait out the Tech Correction Before Picking up Momo Stock

With the FAANG stocks delivering troubling earnings, tech stocks are in some trouble here. Don't expect MOMO stock to be able to avoid the storm in the short-term.

Ericsson Stock Is Heading to at Least $10/Share

With ERIC stock up big in recent months, now is not the time to take profits. Judging off last quarter's results and the outlook for the next year, there is still more upside coming.

As Cloud Kings Go, Red Hat Stock Isn’t Looking Very Regal Right Now

Jim Cramer as lauded Red Hat as one of the winning tech stocks of 2018. Is that still true after a so-so earnings report last month?

Don’t Be Fooled by Pedevco’s 700% Rally: PED Stock Will Plummet

Pedevco stock has rallied as much as 1,000% since June 26th. Unfortunately for its owners, the creditors are the people who will likely end up making the large profit here.

Don’t Let the Navy Contract News Make You Jump on Coda Stock

Coda Octopus is a profitable company with interesting patented technology and an exciting deal with the Navy. But the stock needs to settle back down before being an attractive speculative buy.

Even at $4 Per Share, Gogo Won’t Make You Dough

GOGO stock has crashed. With its massive debts and unproven business model, it's not hard to see why - and the challenges for Gogo aren't going away anytime soon.

ResTORbio Bounces Back: Is the Biotech Stock a Buy?

TORC stock popped earlier this week following positive clinical data. Here's what needs to happen for resTORbio to rally further in coming quarters.

What Musk’s Big China Bet Means for Tesla Stock

Elon Musk announced a huge new factory in China, supposedly in response to the trade war. But here is the real reason for the move, and what it means for TSLA stock.

Can Bank of America Outrun the Financial Sector’s Troubles?

Bank stocks have been getting crushed since February. Bank of America continues to deliver strong earnings numbers, but will that be enough to stop the slide in BAC stock?